Neuroprotective Effects of Meloxicam and Selegiline in Scopolamine-Induced Cognitive Impairment and Oxidative Stress

Table 1

Group-I	Control	Vehicle (0.1% CMC).
Group-II	Disease control	Scopolamine (1.4 mg/kg) i.p.
Group-III	Standard	Donepezil (5 mg/kg) oral + Scopolamine (1.4 mg/kg) i.p.
Group-IV	Test-I	Meloxicam (5.2 mg/kg) oral + Scopolamine (1.4 mg/kg) i.p.
Group-V	Test-II	Selegiline (0.49 mg/kg) p.o. + Scopolamine (1.4 mg/kg) i.p.
Group-VI	Test-III	Meloxicam (5.2 mg/kg) oral + Selegiline (0.49 mg/kg) oral + Scopolamine (1.4 mg/kg) i.p.